Key result
Childhood lifestyle and dietary interventions for dyslipidemia mitigate early CVD risk.
Why the study?
The atherosclerotic process begins in childhood and adolescence is a critical period for its development, necessitating prevention and treatment strategies.
Early identification and management of risk factors such as dyslipidemia through lifestyle and potential pharmacological interventions are crucial for preventing atherosclerosis in children and adolescents.
Adolescent risk assessment by clinicians may enable earlier prevention; leaves open prospective trials on plaque progression interventions.
The atherosclerotic process starts in childhood and studies show its development in fetuses. Clinical manifestation often occurs only in the sixth decade of life. Adolescence is a critical period in the development of atherosclerosis, because fatty streaks may change to transition plaque owing to genetic and environment factors. Healthcare by professionals plays a crucial role in the prevention and treatment of atherosclerosis, identifying poor lifestyle, positive family history of early cardiovascular disease, or other diseases such as dyslipidemia, obesity, arterial hypertension and diabetes. Dyslipidemia in childhood and adolescence should be treating by dietary therapy and change in lifestyle. Children with high-risk lipid abnormalities should be considered for drug treatment.
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2010) conducted a review in Atherosclerosis. Prevention and treatment strategies (lifestyle changes, dietary therapy, drug treatment) was evaluated. Prevention and treatment of atherosclerosis in childhood and adolescence, including lifestyle changes and dietary therapy for dyslipidemia, are crucial to mitigate early cardiovascular disease risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: